Patents Assigned to Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
  • Publication number: 20190241603
    Abstract: The present invention relates to a solid form of a compound of Formula (I), a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and the use of the solid form in the treatment of a disease involving abnormal cell proliferation or a viral infectious disease.
    Type: Application
    Filed: December 15, 2017
    Publication date: August 8, 2019
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Chengxi YANG, Yufeng LIANG, Jiangfeng ZHOU, Jianhua GE, Qiang TIAN, Mingliang ZHAO, Hong ZENG, Fulu ZHAO, Jianfeng HAN, Lichun WANG, Jingyi WANG
  • Publication number: 20190225603
    Abstract: The present invention relates to a dihydropyrimidine compound having an antiviral activity, a pharmaceutical composition comprising same, a preparation method therefor and the uses thereof in the prevention or treatment of viral diseases including, but not limited to, Hepatitis A, Hepatitis B, Hepatitis C, influenza, herpes and acquired immunodeficiency syndrome (AIDS).
    Type: Application
    Filed: November 9, 2017
    Publication date: July 25, 2019
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Shuai SONG, Jiaqiang CAI, Qiang TIAN, Hong ZENG, Hongmei SONG, Hanwen DENG, Zujian TANG, XIAOFAN DUAN, Rongrong LONG, Yao LIU, Lichun WANG, Jingyi WANG
  • Publication number: 20190076438
    Abstract: The present invention provides an anti-ErbB2 antibody-drug conjugate, a composition comprising the conjugate, a method for preparing the conjugate, use of the conjugate.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 14, 2019
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Tongtong XUE, Zhenwei MIAO, Jing WANG, Gang CHEN, Yan QING, Tong ZHU, Liang XIAO, Hong ZHANG, Qiuyan YANG, Dylan Dalun DENG, Liping LIU, Hong ZENG, Li YIN, Qifeng SHI, Hongmei SONG, Xi ZHAO, Lichun WANG, Jingyi WANG
  • Publication number: 20190060291
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Application
    Filed: October 24, 2018
    Publication date: February 28, 2019
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: YINONG XIE, Zejin YOU, Zhiwen DENG, Jun ZHU, Ao WANG, Yan FENG, Dong LONG, Hong ZENG, Hongmei SONG, Qijun YE, Wei QI, Donghai SU, Lichun WANG, Jingyi WANG
  • Patent number: 10159662
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: December 25, 2018
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong Xie, Zejin You, Zhiwen Deng, Jun Zhu, Ao Wang, Yan Feng, Dong Long, Hong Zeng, Hongmei Song, Qijun Ye, Wei Qi, Donghai Su, Lichun Wang, Jingyi Wang
  • Publication number: 20180312511
    Abstract: The present invention relates to a benzodiazepine derivative of Formula I as a short-acting anesthetic, a pharmaceutical composition comprising the same, a kit comprising the same, a preparation method thereof, an method of anesthesia using the same and use thereof in the manufacture of an anesthetic medicament.
    Type: Application
    Filed: December 15, 2016
    Publication date: November 1, 2018
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Gang LIU, Hua YU, Dingju YANG, Jing DU, Jianchuan TANG, Ting HE, Hong ZENG, Hongmei SONG, Donghai SU, Wei LIU, Lichun WANG, Jingyi WANG
  • Publication number: 20180289680
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Application
    Filed: December 8, 2016
    Publication date: October 11, 2018
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong XIE, Zejin YOU, Zhiwen DENG, Jun ZHU, Ao WANG, Yan FENG, Dong LONG, Hong ZHENG, Hongmei SONG, Qijun YE, Wei Qi, Donghai SU, Lichun WANG, Jingyi WANG
  • Publication number: 20180079770
    Abstract: The present invention relates to a novel compound of 4?-thionucleoside, a preparation method therefor, a pharmaceutical composition comprising the same and an application thereof. Specifically, the present invention relates to a phosphamide derivative of 4?-thionucleoside, a preparation method therefor, a pharmaceutical composition comprising the same, a use thereof in the preparation of a medicine for preventing or treating abnormal cell proliferation diseases (for example, tumors or cancers and related diseases) or virus infectious diseases, and a method of using the same for preventing or treating abnormal cell proliferation diseases (for example, tumors or cancers and related diseases) or virus infectious diseases.
    Type: Application
    Filed: March 28, 2016
    Publication date: March 22, 2018
    Applicant: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
    Inventors: Hong YE, Gang LIU, Nan YU, Hong ZENG, Mingliang ZHAO, Yan QING, Hua DENG, Wenjia LI, Donghong LI, Donghai SU, Wei ZHONG, Shaohua LI, Xunwei WU, Lichun WANG, Jingyi WANG